copyright, a relatively innovative medication, has emerged as a potential game-changer in the management of type 2 diabetes. This administered via injection drug targets the incretin hormones GLP-1, which play a vital role in regulating blood sugar levels. By mimicking these hormones, copyright helps lower sugar levels, potentially leading to impro